Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Savara Pharmaceuticals
3225
Savara Pharmaceuticals
Technology
Biotechnology
Health Care
Medical
Pharmaceuticals
Savara Pharmaceuticals develops an inhaled antibiotic for MRSA infection inCystic Fibrosis
Suggest edits
Type
B2c
Founded
2007
Raised
$103.9M
Follow us
Also headquartered in Austin
AMD
SXSW
Gigaom
OpenStack
SolarWinds
2FA, Inc.
Vista Equity Partners
Whole Foods Market
HomeAway
BigCommerce
Companies in the same industry
Prokarium
PharmaFluidics
Haoma Medica Ltd.
Suzhou Zelgen Biopharmaceuticals
Genprex, Inc.
Modulus Discovery
CRAMbridge
Aden Healthcare
ASDERA
ROME Therapeutics
Alexa global traffic share
Overview
Funding
6
Add info
Latest funding
Show all
$47,000,000
Post-IPO equity - 2017
$15,000,000
Debt financing - 2017
Silicon Valley Bank
Team Size
2
Employees
I work here
Location
Austin
,
United States
Headquarters
Explore Austin
$15,000,000
Debt financing
texastechpulse
Savara Gets $15M In Debt Funding From SVB
Xconomy
Inhaled-Drug Maker Savara Buys European Biotech With Two Candidates
Health
$20,000,000
Venture capital (Series C)
FinSMEs
,
Xconomy
Savara Pharmaceuticals Closes $20M Series C Financing
Health
Funding
